Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Etoposide | 0.01 | uM | 5 | 625.00 | 399.25 | 8997.00 | 8870.50 | 1.0143 | 1.0063 |
MCF 10A | NVP-TAE684 | 3.1623 | uM | 5 | 625.00 | 399.25 | 781.00 | 8870.50 | 0.0880 | 0.1618 |
MCF 10A | Etoposide | 0.31623 | uM | 5 | 625.00 | 399.25 | 1808.00 | 8870.50 | 0.2038 | 0.4016 |
MCF 10A | PLX-4720 | 0.0033113 | uM | 5 | 625.00 | 399.25 | 8693.00 | 8870.50 | 0.9800 | 0.9910 |
MCF 10A | NVP-TAE684 | 0.01 | uM | 5 | 625.00 | 399.25 | 9284.00 | 8870.50 | 1.0466 | 1.0205 |
MCF 10A | Etoposide | 0.0033113 | uM | 5 | 625.00 | 399.25 | 9850.00 | 8870.50 | 1.1104 | 1.0474 |
MCF 10A | PLX-4720 | 10 | uM | 5 | 625.00 | 399.25 | 7561.00 | 8870.50 | 0.8524 | 0.9299 |
MCF 10A | Etoposide | 3.1623 | uM | 5 | 625.00 | 399.25 | 375.00 | 8870.50 | 0.0423 | -0.0139 |
MCF 10A | Nilotinib | 19.9526 | uM | 5 | 625.00 | 399.25 | 880.00 | 8870.50 | 0.0992 | 0.1932 |
MCF 10A | Nilotinib | 0.1 | uM | 5 | 625.00 | 399.25 | 9052.00 | 8870.50 | 1.0205 | 1.0091 |
MCF 10A | PLX-4720 | 0.1 | uM | 5 | 625.00 | 399.25 | 8782.00 | 8870.50 | 0.9900 | 0.9955 |
MCF 10A | PLX-4720 | 1 | uM | 5 | 625.00 | 399.25 | 9250.00 | 8870.50 | 1.0428 | 1.0188 |
MCF 10A | NVP-TAE684 | 0.1 | uM | 5 | 625.00 | 399.25 | 6753.00 | 8870.50 | 0.7613 | 0.8817 |
MCF 10A | Nilotinib | 10 | uM | 5 | 625.00 | 399.25 | 2818.00 | 8870.50 | 0.3177 | 0.5478 |
MCF 10A | Nilotinib | 0.01 | uM | 5 | 625.00 | 399.25 | 8662.00 | 8870.50 | 0.9765 | 0.9894 |
MCF 10A | Etoposide | 19.9526 | uM | 5 | 625.00 | 399.25 | 334.00 | 8870.50 | 0.0377 | -0.0391 |
MCF 10A | 0 | uM | 5 | 625.00 | 399.25 | 8722.00 | 8870.50 | 0.9833 | 0.9925 | |
MCF 10A | 0 | uM | 5 | 625.00 | 399.25 | 9094.00 | 8870.50 | 1.0252 | 1.0112 | |
MCF 10A | 0 | uM | 5 | 625.00 | 399.25 | 9366.00 | 8870.50 | 1.0559 | 1.0244 | |
MCF 10A | 0 | uM | 5 | 625.00 | 399.25 | 8516.00 | 8870.50 | 0.9600 | 0.9819 | |
MCF 10A | Etoposide | 1 | uM | 5 | 625.00 | 399.25 | 560.00 | 8870.50 | 0.0631 | 0.0786 |
MCF 10A | NVP-TAE684 | 0.0016596 | uM | 5 | 625.00 | 399.25 | 8634.00 | 8870.50 | 0.9733 | 0.9880 |
MCF 10A | 0 | uM | 5 | 625.00 | 399.25 | 8877.00 | 8870.50 | 1.0007 | 1.0003 | |
MCF 10A | NVP-TAE684 | 10 | uM | 5 | 625.00 | 399.25 | 346.00 | 8870.50 | 0.0390 | -0.0315 |
MCF 10A | Nilotinib | 0.0033113 | uM | 5 | 625.00 | 399.25 | 9471.00 | 8870.50 | 1.0677 | 1.0295 |